Ardsley Advisory Partners LP Pro Qr Therapeutics N.V. Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$5.25 - $9.9 $105,000 - $198,000	-20,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.84 - $10.51 $116,800 - $210,200	20,000 New	20,000 $198,000
Q4 2018 Feb 14, 2019	SELL	$15.25 - $22.4 $381,250 - $560,000	-25,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$6.45 - $21.6 $161,250 - $540,000	-25,000 Reduced 50.0%	25,000 $484,000
Q2 2018 Aug 14, 2018	BUY	$2.95 - $7.45 $147,500 - $372,500	50,000 New	50,000 $365,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $188M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.